AML (Acute Myeloid Leukemia) diagnostics

Diagnosing Acute Myeloid Leukemia (AML) involves blood tests to identify abnormal white blood cells, including a complete blood count (CBC) and microscopy to examine cell appearance. A bone marrow biopsy is often performed to analyze marrow cells directly. Additional tests like cytogenetics and molecular studies identify genetic mutations and chromosomal abnormalities that help confirm AML and guide treatment. These diagnostics differentiate AML from other blood disorders, determine subtype, and provide important information about prognosis. Together, they enable healthcare providers to establish an accurate diagnosis and develop an effective treatment plan.